Literature DB >> 3281608

Autoantibody profile in juvenile chronic arthritis.

A M Leak1.   

Abstract

Patients with juvenile chronic arthritis (JCA) may be subdivided into a minority, who carry IgM rheumatoid factor and have erosive polyarthritis resembling adult rheumatoid arthritis, and the majority (90%), who are seronegative by conventional means. Between 30 and 60% of patients with JCA have positive antinuclear antibodies (ANAs) according to the choice of substrate for indirect immunofluorescence. The importance of ANAs is the frequent development of associated asymptomatic chronic iridocyclitis, which may impair vision causing worse handicap than the arthritis, which remains predominantly pauciarticular in two thirds of these young children. ANA positive patients rarely possess antibodies to deoxyribonucleic acid (DNA) or extractable nuclear antigens (ENA), and current studies suggest that several different nuclear antigens, including histones, may be involved.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281608      PMCID: PMC1003480          DOI: 10.1136/ard.47.3.178

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  52 in total

1.  Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  C Bell; N Talal; P H Schur
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

2.  Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis.

Authors:  R E Petty; J T Cassidy; D B Sullivan
Journal:  J Pediatr       Date:  1973-09       Impact factor: 4.406

3.  Antinuclear antibodies in infectious mononucleosis.

Authors:  M E Kaplan; E M Tan
Journal:  Lancet       Date:  1968-03-16       Impact factor: 79.321

4.  Selective IgA deficiency: presentation of 30 cases and a review of the literature.

Authors:  A J Ammann; R Hong
Journal:  Medicine (Baltimore)       Date:  1971-05       Impact factor: 1.889

5.  A study of specificities of antinuclear antibodies in juvenile rheumatoid arthritis.

Authors:  M A Alspaugh; J J Miller
Journal:  J Pediatr       Date:  1977-03       Impact factor: 4.406

6.  Anterior uveitis in juvenile rheumatoid arthritis.

Authors:  J J Kanski
Journal:  Arch Ophthalmol       Date:  1977-10

7.  Clinical features and serologic abnormalities in juvenile rheumatoid arthritis.

Authors:  R D Rudnicki; M Ruderman; E Scull; A Goldenberg; N Rothfield
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

8.  Immunologic studies of juvenile rheumatoid arthritis.

Authors:  N E Bianco; R S Panush; J S Stillman; P H Schur
Journal:  Arthritis Rheum       Date:  1971 Nov-Dec

9.  Granulocyte reactive antinuclear factors in juvenile rheumatoid arthritis.

Authors:  H M Hoyeraal
Journal:  Scand J Rheumatol       Date:  1976       Impact factor: 3.641

10.  Antinuclear antibody studies in juvenile chronic arthritis.

Authors:  A M Leak; B M Ansell; S J Burman
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

View more
  5 in total

Review 1.  Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones.

Authors:  A M Leak; P Woo
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

2.  Identification of antihistone antibodies in subsets of juvenile chronic arthritis.

Authors:  M Ostensen; K Fredriksen; E Kåss; O P Rekvig
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

3.  Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives.

Authors:  T R Southwood; P J Roberts-Thomson; M J Ahern; K Shepherd; R McEvoy; J B Ziegler; J Edmonds
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

4.  Prevalence of anticardiolipin antibodies in juvenile chronic arthritis.

Authors:  R Caporali; A Ravelli; F De Gennaro; G Neirotti; C Montecucco; A Martini
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

5.  Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis.

Authors:  J Sieper; J Braun; E Döring; P Wu; J Heesemann; J Treharne; G Kingsley
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.